- Home
- HYI vs MBOT Comparison
HYI vs MBOT Comparison
Compare HYI & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HYI | MBOT |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.8M | 145.7M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | HYI | MBOT |
|---|---|---|
| Price | $10.84 | $2.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 43.3K | ★ 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 9.59% | N/A |
| EPS Growth | N/A | ★ 30.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4,200.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.87 | $1.35 |
| 52 Week High | $12.12 | $4.62 |
Technical Indicators
Market Signals| Indicator | HYI | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 28.54 | 58.45 |
| Support Level | $10.87 | $2.34 |
| Resistance Level | $11.21 | $2.64 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 16.28 | 62.14 |
Price Performance
Historical ComparisonAbout HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.